Health ❯ Healthcare ❯ Pharmaceuticals

Regulatory Affairs

FDA FDA Approval Drug Approval Quality Control FDA Approvals FDA Compliance FDA Regulations Marketing Authorization Marketing Compliance Counterfeit Products Clinical Trials FDA Submissions ANSM Regulations Marketing Authorisation Drug Development Medication Safety NDMA Contamination FDA Recall FDA Peptide Review Clinical Research FDA Rejection Pharma Accountability Clinical Trial Results Good Manufacturing Practices EMA Recommendations Label Updates FDA Enforcement International Standards FDA Approval Process Drug Recall Drug Regulation European Medicines Agency FDA Actions Anvisa Pharmacovigilance

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

The FDA labeled the ongoing action Class II to signal possible temporary harms.

FDA Warns ImmunityBio Over Anktiva Ads, Citing Misleading Cancer Claims

uniQure Investors Face April 13 Deadline in Securities Class Action Over FDA Setback

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

FDA Accepts Sonrotoclax NDA, Grants Priority Review for Relapsed Mantle Cell Lymphoma

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

EU Regulators Back Libtayo as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma

Savara Investors Pressed to Seek Lead Role in Securities Suit Before Nov. 7 Deadline